PortfoliosLab logoPortfoliosLab logo
MED vs. GLD
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

MED vs. GLD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medifast, Inc. (MED) and SPDR Gold Shares (GLD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MED achieves a 11.33% return, which is significantly higher than GLD's -2.47% return. Over the past 10 years, MED has underperformed GLD with an annualized return of -7.29%, while GLD has yielded a comparatively higher 12.15% annualized return.


MED

1D
-0.25%
1M
-4.73%
YTD
11.33%
6M
-3.80%
1Y
-8.40%
3Y*
-46.74%
5Y*
-45.89%
10Y*
-7.29%

GLD

1D
0.06%
1M
-7.37%
YTD
-2.47%
6M
-2.25%
1Y
22.21%
3Y*
28.89%
5Y*
17.08%
10Y*
12.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MED vs. GLD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MED
Medifast, Inc.
11.33%-39.39%-73.79%-38.34%-42.31%9.36%86.18%-9.73%82.11%72.33%
GLD
SPDR Gold Shares
-2.47%63.68%26.66%12.69%-0.77%-4.15%24.81%17.86%-1.94%12.81%

Correlation

The correlation between MED and GLD is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.02

Correlation (5Y)
Calculated over the trailing 5-year period

0.04

Correlation (10Y)
Calculated over the trailing 10-year period

0.03

Correlation (All Time)
Calculated using the full available price history since Nov 18, 2004

0.04

The correlation between MED and GLD shifts across timeframes, from -0.07 (1 year) to 0.04 (5 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MED vs. GLD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MED
MED Risk / Return Rank: 3333
Overall Rank
MED Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
MED Sortino Ratio Rank: 3030
Sortino Ratio Rank
MED Omega Ratio Rank: 3131
Omega Ratio Rank
MED Calmar Ratio Rank: 3535
Calmar Ratio Rank
MED Martin Ratio Rank: 3535
Martin Ratio Rank

GLD
GLD Risk / Return Rank: 2626
Overall Rank
GLD Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
GLD Sortino Ratio Rank: 2525
Sortino Ratio Rank
GLD Omega Ratio Rank: 3030
Omega Ratio Rank
GLD Calmar Ratio Rank: 2424
Calmar Ratio Rank
GLD Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MED vs. GLD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medifast, Inc. (MED) and SPDR Gold Shares (GLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MEDGLDDifference
Sharpe ratioReturn per unit of total volatility

-1.11

Sortino ratioReturn per unit of downside risk

-1.30

Omega ratioGain probability vs. loss probability

0.99

1.18

-0.19

Calmar ratioReturn relative to maximum drawdown

-0.26

0.98

-1.24

Martin ratioReturn relative to average drawdown

-0.44

2.81

-3.25

MED vs. GLD - Sharpe Ratio Comparison

The current MED Sharpe Ratio is -0.23, which is lower than the GLD Sharpe Ratio of 0.87. The chart below compares the historical Sharpe Ratios of MED and GLD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MED vs. GLD - Drawdown Comparison

The maximum MED drawdown since its inception was -98.40%, which is greater than GLD's maximum drawdown of -45.56%. Use the drawdown chart below to compare losses from any high point for MED and GLD.


Loading charts...

Drawdown Indicators


MEDGLDDifference

Max Drawdown

Largest peak-to-trough decline

-98.40%

-45.56%

-52.84%

Max Drawdown (1Y)

Largest decline over 1 year

-37.39%

-24.46%

-12.93%

Max Drawdown (3Y)

Largest decline over 3 years

-90.91%

-24.46%

-66.45%

Max Drawdown (5Y)

Largest decline over 5 years

-96.29%

-24.46%

-71.83%

Max Drawdown (10Y)

Largest decline over 10 years

-96.76%

-24.46%

-72.30%

Current Drawdown

Current decline from peak

-95.96%

-22.05%

-73.91%

Average Drawdown

Average peak-to-trough decline

-50.84%

-16.16%

-34.68%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.83%

8.49%

+13.34%

Volatility

MED vs. GLD - Volatility Comparison

Medifast, Inc. (MED) has a higher volatility of 8.94% compared to SPDR Gold Shares (GLD) at 7.79%. This indicates that MED's price experiences larger fluctuations and is considered to be riskier than GLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MEDGLDDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.94%

7.79%

+1.15%

Volatility (6M)

Calculated over the trailing 6-month period

31.69%

24.10%

+7.59%

Volatility (1Y)

Calculated over the trailing 1-year period

41.90%

27.37%

+14.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.25%

18.22%

+27.03%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.68%

16.08%

+31.60%

Dividends

MED vs. GLD - Dividend Comparison

Neither MED nor GLD has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
GLD
SPDR Gold Shares
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MED
Medifast, Inc.
0.00%0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%

Frequently Asked Questions


MED and GLD have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MED has higher volatility (8.94%) compared to GLD (7.79%). In terms of maximum drawdown, MED dropped -98.40% vs GLD's -45.56%.

GLD currently has the higher Sharpe Ratio (0.87 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MED and GLD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer